Question 1

Purpose of the Assessment

Accepted Answer

Accurately differentiate between benign fibroids and uterine sarcoma Determine the most appropriate treatment strategy based on risk level Minimize the need for unnecessary surgical interventions

Question 2

Target Groups

Accepted Answer

Women with rapidly growing uterine masses High-risk pregnancy cases with suspicious uterine findings Patients with a strong family history of uterine malignancies

Question 3

Frequently Asked Questions

Accepted Answer

Is the procedure painful? No, it involves blood work and non-invasive imaging. When will results be ready? Results are typically available within 3-5 working days.

Precise Uterine Sarcoma Risk Assessment - Uterine Sarcoma Risk Stratification Program